NEW YORK: Novartis AG, Merck & Co Inc and Allergan Plc were among companies that raised U.S. prices on more than 100 prescription medicines on Friday, bringing the tally to 445 drugs that will cost more in 2020, according to data analyzed by healthcare research firm 3 Axis Advisors.
U.S. drugmaker Merck raised prices on about 15 drugs, including diabetes medicines Januvia and Janumet, mostly around 5per cent, 3 Axis said. Reuters previously reported that Pfizer Inc, Bristol-Myers Squibb Co and AbbVie were among drugmakers that had raised prices on more than 330 drugs to start the year.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessTimes - 🏆 15. / 51 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »